1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
5.1.1.3. Government intervention for the use of pediatric vaccines
5.1.2. Restraints
5.1.2.1. Lack of implementation of mandatory vaccination
5.1.2.2. Slight-side effects associated with pediatric vaccines
5.1.3. Opportunities
5.1.3.1. Strong late-stage pipeline and new drug approvals
5.1.3.2. Routinized vaccines used in immunization of infants and children
5.1.4. Challenges
5.1.4.1. No uniform recall or reminder system and staff shortages
5.2. Cumulative Impact of COVID-19

6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Multivalent

8. Pediatric Vaccines Market, by End User
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization

9. Pediatric Vaccines Market, by Indication
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever

10. Americas Pediatric Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pediatric Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Pediatric Vaccines Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. AstraZeneca PLC
14.2. CSL Limited
14.3. Eli Lilly and Company
14.4. GlaxoSmithKline PLC
14.5. Merck Sharp & Dohme Corp.
14.6. Mitsubishi Chemical Corporation
14.7. Novartis AG
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2018-2027 (USD BILLION)
FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2018-2027 (USD BILLION)
FIGURE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (%)
FIGURE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2027
FIGURE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2027 (USD BILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2027
FIGURE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
FIGURE 37. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD BILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2027
FIGURE 39. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2018-2027 (USD BILLION)
FIGURE 40. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2018-2027 (USD BILLION)
FIGURE 42. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 43. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2018-2027 (USD BILLION)
FIGURE 44. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 45. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2018-2027 (USD BILLION)
FIGURE 46. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 47. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2018-2027 (USD BILLION)
FIGURE 48. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 49. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2018-2027 (USD BILLION)
FIGURE 50. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 51. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2018-2027 (USD BILLION)
FIGURE 52. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 53. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2018-2027 (USD BILLION)
FIGURE 54. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 55. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2018-2027 (USD BILLION)
FIGURE 56. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 57. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2018-2027 (USD BILLION)
FIGURE 58. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 59. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2018-2027 (USD BILLION)
FIGURE 60. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 61. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2018-2027 (USD BILLION)
FIGURE 62. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 63. AMERICAS PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. BRAZIL PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. CANADA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. MEXICO PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. CHINA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. INDIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. INDONESIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. JAPAN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. TAIWAN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. THAILAND PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. FRANCE PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. GERMANY PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. ITALY PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. QATAR PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. RUSSIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. SPAIN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 91. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 92. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 93. GLOBAL PEDIATRIC VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 94. GLOBAL PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 95. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PEDIATRIC VACCINES MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL PEDIATRIC VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. AMERICAS PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. BRAZIL PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. CANADA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. MEXICO PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. CHINA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. INDIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. INDONESIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. JAPAN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. TAIWAN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. THAILAND PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. FRANCE PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 51. GERMANY PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 52. ITALY PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 54. QATAR PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 55. RUSSIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 56. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 57. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 58. SPAIN PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 59. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 60. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 61. GLOBAL PEDIATRIC VACCINES MARKET: SCORES
TABLE 62. GLOBAL PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 63. GLOBAL PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 64. GLOBAL PEDIATRIC VACCINES MARKET: RANKING
TABLE 65. GLOBAL PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 66. GLOBAL PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 67. GLOBAL PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 68. GLOBAL PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 69. GLOBAL PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 70. GLOBAL PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 71. GLOBAL PEDIATRIC VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

AstraZeneca PLC
CSL Limited
Eli Lilly and Company
GlaxoSmithKline PLC
Merck Sharp & Dohme Corp.
Mitsubishi Chemical Corporation
Novartis AG
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.